Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
- 1 January 2022
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 288, 119948
Abstract
No abstract availableKeywords
Funding Information
- National University of Singapore
- Ministry of Education - Singapore (MOE-T2EP30120-0016)
- National Medical Research Council
This publication has 231 references indexed in Scilit:
- Landscape of transcription in human cellsNature, 2012
- shRNA Targeting PLCε Inhibits Bladder Cancer Cell Growth In Vitro and In VivoUrology, 2011
- Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expressionProceedings of the National Academy of Sciences, 2009
- Evolution and Functions of Long Noncoding RNAsCell, 2009
- Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancerOncogene, 2007
- PD‐L1 (B7‐H1) expression by urothelial carcinoma of the bladder and BCG‐induced granulomataCancer, 2007
- Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancersCancer Immunology, Immunotherapy, 2006
- A versatile tool for conditional gene expression and knockdownNature Methods, 2006
- Regulatable gene expression systems for gene therapy applications: progress and future challengesMolecular Therapy, 2005
- shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activityCancer Chemotherapy and Pharmacology, 2005